85 results
Page 3 of 5
8-K
EX-99.1
1801ek 4o
7 Nov 18
Aerpio Reports Third Quarter 2018 Financial Results and Provides Business Update
7:18am
8-K
EX-99.1
wxbogmb6dachn
14 Aug 18
Aerpio Reports Second Quarter 2018 Financial Results and Provides Business Update
7:23am
8-K
EX-1.1
su1ig70aa
27 Jun 18
Aerpio Pharmaceuticals Announces Proposed Public Offering of Common Stock and Uplisting to Nasdaq Capital Market
4:56pm
424B5
wjer1z ttgio1c4yafc
26 Jun 18
Prospectus supplement for primary offering
9:30am
424B5
gvvzm5sf5nwotdp8l5i
25 Jun 18
Prospectus supplement for primary offering
5:08pm
424B3
cto8f og38gudi9jnpp
25 Jun 18
Prospectus supplement
8:33am
8-K
EX-99.1
h9791nef
25 Jun 18
Entry into a Material Definitive Agreement
8:25am
424B3
ml0d 17mhym1y917es4
25 May 18
Prospectus supplement
4:33pm
424B3
qt5u3ss7xmlha1b8ncu
25 May 18
Prospectus supplement
4:29pm
8-K
EX-99.1
xuyt5tglxhkj6s5vj2
15 May 18
Aerpio Reports First Quarter 2018 Financial Results and Provides Company Update
9:28am
DEF 14A
pnula3l87x
15 May 18
Definitive proxy
12:00am
PREM14C
dnjaaa0
17 Mar 17
Preliminary information related to merger
12:00am